Click the link on the right to access the full report
While the sustainability of healthcare provision is under ever-increasing pressure throughout Europe, the price of medicines is not a major risk for health systems, according to a vote by participants at a Friends of Europe debate in Brussels.
The initial perception of the audience changed after hearing the Oxford Union style ‘for’ and ‘against’ debate between Thomas Allvin, Executive Director for Strategy and Healthcare Systems at the European Federation of Pharmaceutical Industries Association (EFPIA), and Jo De Cock, CEO of the Belgian National Institute for Health and Disability Insurance (INAMI).
Audience members were polled at the beginning and end of the Sustainability of Healthcare event, on 28 November, which debated the motion: ‘This House believes that the price of medicines is not a major risk for health systems’. The pre-debate vote showed 39% in favour, but after each speaker made their case and took questions, 62% supported it.
IMAGE CREDIT: anekoho/Bigstock